Cns Pharmaceuticals Inc (CNSP)

Nov 19, 2024

CNS Pharmaceuticals (NASDAQ: CNSP) to Present Berubicin Trial Update at Society for Neuro-Oncology Annual Meeting - Barchart

Nov 19, 2024

Nov 18, 2024

CNS Pharmaceuticals (NASDAQ: CNSP) Advances Glioblastoma Treatment With Berubicin - Barchart

Nov 18, 2024

Nov 18, 2024

CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024) - AccessWire

Nov 18, 2024

Nov 15, 2024

CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results - AccessWire

Nov 15, 2024

Nov 15, 2024

CNS Pharmaceuticals Inc (CNSP) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in CNS Pharmaceuticals Inc - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

CNS Pharmaceuticals: Financial Results and Strategic Moves - TipRanks

Nov 14, 2024

Nov 06, 2024

CNS Pharmaceuticals’ $3 Million Common Stock Offering - Global Legal Chronicle

Nov 06, 2024

Nov 04, 2024

CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment - AccessWire

Nov 04, 2024

Nov 04, 2024

CNS Pharmaceuticals (NASDAQ: CNSP) Highlights Berubicin’s Potential During KOL Connect Event - Barchart

Nov 04, 2024

Nov 03, 2024

CNS Pharmaceuticals Receives Temporary Exception from NASDAQ Regarding Minimum Bid Price Requirement - Defense World

Nov 03, 2024

Nov 01, 2024

CNS Pharmaceuticals granted Nasdaq compliance extension By Investing.com - Investing.com South Africa

Nov 01, 2024

Nov 01, 2024

CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

CNS Pharmaceuticals granted Nasdaq compliance extension - Investing.com

Nov 01, 2024

Nov 01, 2024

CNSPCNS Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Nov 01, 2024

Oct 25, 2024

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG - Financial Content

Oct 25, 2024

Oct 23, 2024

CNS Pharmaceuticals faces NASDAQ delisting over price rule By Investing.com - Investing.com Australia

Oct 23, 2024

Oct 23, 2024

CNS Pharmaceuticals secures $3 million in registered direct offering - Investing.com

Oct 23, 2024

Oct 23, 2024

CNS Pharmaceuticals secures $3 million in registered direct offering By Investing.com - Investing.com UK

Oct 23, 2024

Oct 23, 2024

CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - AccessWire

Oct 23, 2024

Oct 23, 2024

CNS Pharmaceuticals faces NASDAQ delisting over price rule - Investing.com

Oct 23, 2024

Oct 14, 2024

Stock Performance Spotlight: Cns Pharmaceuticals Inc (CNSP) Ends the Day at 0.12, Up by 0.77 - The Dwinnex

Oct 14, 2024

Oct 14, 2024

Can you still get a good price for Cns Pharmaceuticals Inc (CNSP) Shares at this point? - US Post News

Oct 14, 2024

Oct 11, 2024

CNS Pharmaceuticals (NASDAQ: CNSP) Management Participates In Virtual Investor KOL Connect Segment - Barchart

Oct 11, 2024

Oct 11, 2024

Cns Pharmaceuticals Inc (CNSP-Q) QuotePress Release - The Globe and Mail

Oct 11, 2024

Oct 11, 2024

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum - MSN

Oct 11, 2024

Oct 10, 2024

It is Poised to be a Bull Market for Cns Pharmaceuticals Inc (CNSP) - SETE News

Oct 10, 2024

Oct 10, 2024

CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment - BioSpace

Oct 10, 2024

Oct 09, 2024

Ladenburg Thalmann gives a Neutral recommendation for Cns Pharmaceuticals Inc (CNSP) - Knox Daily

Oct 09, 2024

Oct 08, 2024

Cns Pharmaceuticals Inc (CNSP) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Oct 08, 2024

Oct 08, 2024

CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC - StockTitan

Oct 08, 2024

Oct 07, 2024

A stock that deserves closer examination: Cns Pharmaceuticals Inc (CNSP) - US Post News

Oct 07, 2024

Oct 07, 2024

Ratio Examination: Cns Pharmaceuticals Inc (CNSP)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 07, 2024

Oct 03, 2024

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference - The Manila Times

Oct 03, 2024

Oct 02, 2024

Wall Street analysts’ outlook for Cns Pharmaceuticals Inc (CNSP) - SETE News

Oct 02, 2024

Oct 01, 2024

Cns Pharmaceuticals Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle

Oct 01, 2024

Oct 01, 2024

Titan Medical Inc (TMD-T) QuotePress Release - The Globe and Mail

Oct 01, 2024

Oct 01, 2024

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024 - The Manila Times

Oct 01, 2024

Sep 30, 2024

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - ForexTV.com

Sep 30, 2024

Sep 30, 2024

Cns Pharmaceuticals Inc (CNSP)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Sep 30, 2024

Sep 30, 2024

Examining Cns Pharmaceuticals Inc (CNSP) stock is warranted - US Post News

Sep 30, 2024

Sep 30, 2024

CNS Therapeutics Market 2024 Share, Growth Forecast and Industry Outlook 2032 | Eli Lilly and Co. - 대구포스트

Sep 30, 2024

Sep 27, 2024

CNS Pharma (NASDAQ:CNSP) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024

Sep 25, 2024

A new trading data show Cns Pharmaceuticals Inc (CNSP) is showing positive returns. - SETE News

Sep 25, 2024

Sep 24, 2024

Do investors need to be concerned about Cns Pharmaceuticals Inc (CNSP)? - US Post News

Sep 24, 2024

Sep 24, 2024

CNS (Central Nervous System) Therapeutics Market 2024 Size, Status and Global Outlook 2031 - Newstrail

Sep 24, 2024

Sep 23, 2024

CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum - AccessWire

Sep 23, 2024